Finally, Pacheco and O Nielsen [93] tried to elucidate the role of HDAC-1 and HDAC-2 in a large series of mesenchymal tumors, comprised of 1332 cases, representing 44 categories of both malignant and borderline tumors. Here, HDAC2 is linked to mesenchymal cell neoplasm.